1. Exploring clinical predictors of severe human metapneumovirus respiratory tract infections in children : insights from a recent outbreakAirin Veronese, Tina Uršič, Simona Bizjak, Jasna Rodman, 2024, izvirni znanstveni članek Povzetek: Human metapneumovirus (hMPV) is an important pathogen that causes both upper (URTIs) and lower respiratory tract infections (LRTIs) in children. The virus can be implicated in severe bronchiolitis and pneumonia, necessitating hospitalization, with certain cases requiring intensive care unit intervention. As part of a retrospective observational study, we aimed to identify indicators of severe hMPV respiratory tract infections in children referred to the University Children’s Hospital Ljubljana and the Department of Infectious Diseases Ljubljana, Slovenia, during a recent outbreak. We analyzed clinical data from November 2022 to January 2023 and compared the characteristics of children presenting with URTIs and LRTIs. We also examined the characteristics of children with hMPV LRTIs, distinguishing between children with and without LRTI-associated hypoxemia. Of 78 hMPV-PCR-positive pediatric patients (mean age 3.1 years; 60.3% boys), 36% had a URTI, and 64% had an LRTI. Hospitalization was required in 64% (50/78), with 42% (21/50) requiring oxygen therapy. LRTI-associated hypoxemia was more common in patients with atopy who showed dyspnea, tachypnea, crackles, and wheezing on lung auscultation. In a multivariable logistic regression analysis, wheezing detected on lung auscultation was a significant predictive factor for hypoxemic hMPV-LRTI. Specifically, children presenting with wheezing were found to be ten times more likely to experience hypoxemia. Prematurity and chronic conditions did not influence the presentation or severity of hMPV infection. This study highlights wheezing and atopy as crucial indicators of severe hMPV LRTI in children, emphasizing the importance of early recognition and intervention. Ključne besede: human metapneumovirus, respiratory tract infection, oxygen therapy, wheezing, atopy, asthma, children Objavljeno v DiRROS: 12.06.2026; Ogledov: 64; Prenosov: 46
Celotno besedilo (621,15 KB) Gradivo ima več datotek! Več... |
2. Melatonin vs. dexmedetomidine for sleep induction in children before electroencephalographyKatja Peganc, David Neubauer, Jasna Oražem, Mirjana Perković-Benedik, Urška Mahne, Neli Bizjak, Zvonka Rener-Primec, Nataša Šuštar, Tita Butenko, Eva Vrščaj, Damjan Osredkar, 2024, izvirni znanstveni članek Ključne besede: melatonin, dexmedetomidine, electroencephalography, EEG, sleep, sleep induction Objavljeno v DiRROS: 08.06.2026; Ogledov: 113; Prenosov: 41
Celotno besedilo (625,42 KB) |
3. |
4. |
5. Vpliv nekaterih dejavnikov na bralne navade študentov univerzitetnih pedagoških programovJasna Mažgon, Miha Kovač, Mojca Kovač Šebart, 2025, izvirni znanstveni članek Povzetek: Izsledki raziskave, opravljene leta 2024/25 na izbranem vzorcu študentov univerzitetnih pedagoških programov v Sloveniji, kažejo, da so dejavniki, ki pomembno vplivajo na število prebranih knjig v odraslosti, zlasti branje v družini v otroštvu, izobrazba matere in tudi vključenost v vrtec. Na bralne navade študentov in študentk pomembno vplivata tudi branje iz veselja in motivacija za branje. Podatki ponovljene raziskave 2024/25 so slabši od tistih iz raziskave, ki smo jo opravili leta 2017/18. Študentke in študenti branju tedensko namenjajo manj časa, pogosteje kot leta 2017/18 pa izbirajo manj zahtevna besedila, a preberejo več knjig. Študentke so pri tem učinkovitejše od študentov, a so besedila, ki jih izbirajo, manj zahtevna; študenti pogosteje izbirajo zahtevnejša besedila in pogosteje v njih iščejo odgovore na vprašanja, ki jih zanimajo. Kar 30 % študentov je odgovorilo, da ne berejo, tako je odgovorilo 15 % študentk. Oboje je skrb zbujajoč podatek tudi za izvajalce visokošolskih pedagoških programov. Ključne besede: bralne navade študentov, branje v družini, motivacija za branje, vključenost v vrtec, branje po spolu Objavljeno v DiRROS: 20.05.2026; Ogledov: 156; Prenosov: 91
Celotno besedilo (215,14 KB) Gradivo ima več datotek! Več... |
6. Obravnava ploda in novorojenčka s cistično fibrozoSimona Capl, Jasna Rodman, Uroš Krivec, Marina Praprotnik, Aneta Soltirovska Šalamon, Jernej Brecelj, Anja Praprotnik Novak, Anija Orel, Daša Perko, Majda Oštir, Sandra Cerar, 2026, pregledni znanstveni članek Povzetek: Cistična fibroza (CF) je najpogostejša avtosomno recesivna genetska bolezen, pri kateri so prizadeti številni organski sistemi, predvsem dihala, prebavila, endokrini sistem in reproduktivni organi. Določene morfološke spremembe pri plodu lahko odkrijemo že pred rojstvom. Po rojstvu lahko zaradi zapore prebavil ob mekonijskem ileusu pride do življenje ogrožujočih zapletov. Bolezen se najpogosteje klinično izrazi v zgodnjem otroštvu, vendar ima lahko že novorojenček pomanjkljivo delovanje trebušne slinavke. CF pri novorojenčkih odkrivamo s presejalnim testiranjem. Poleg dosedanje obravnave, ki pri bolnikih s CF vključuje respiratorno fizioterapijo, aktivno iskanje in zdravljenje okužb, skrb za primerno prehranjenost ter nadomeščanje encimov, vitaminov in mineralov, pa se je zaradi uvedbe novejših zdravil (modulatorjev regulatorja transmembranske prevodnosti pri CF oz. CFTR modulatorjev) močno spremenil potek bolezni in se izboljšala reproduktivna sposobnost žensk. Ker na potek nosečnosti zaenkrat ni dokazanega pomembnega negativnega vpliva, noseče bolnice pogosto nadaljujejo z zdravljenjem tudi med nosečnostjo. CFTR modulatorji prehajajo preko posteljice in se izločajo z materinim mlekom. Ker je ob odkritju bolezni pri novorojenčku potrebna obravnava, smo izdelali priporočila. V prispevku opisujemo tudi pogled na zdravljenje ploda s CF že prenatalno in obravnavo novorojenčka, ki je bil kot plod izpostavljen zdravilom za CF zaradi zdravljenja matere s CF med nosečnostjo. Ključne besede: cistična fibroza, plod, novorojenček, nosečnost, CFTR modulatorji, mekonijski ileus Objavljeno v DiRROS: 06.05.2026; Ogledov: 237; Prenosov: 120
Celotno besedilo (375,95 KB) Gradivo ima več datotek! Več... |
7. Impact of elexacaftor/tezacaftor/ivacaftor on the presence of bacterial and fungal pathogens in the lower respiratory tract of children with cystic fibrosisGaja Setnikar Kimovec, Katja Seme, Tadeja Matos, Vesna Špik, Uroš Krivec, Marina Praprotnik, Jasna Rodman, 2026, izvirni znanstveni članek Povzetek: Background: Highly effective CFTR modulator therapy, such as elexacaftor/tezacaftor/ivacaftor (ETI), has been linked to significant clinical improvements in people with cystic fibrosis (pwCF). However, its effect on the presence of respiratory pathogens in the lower respiratory tract of younger, mainly non-expectorant children with CF remains poorly understood, especially using lower airway sampling methods. We aimed to investigate changes in lower airway microbiology and clinical outcomes in children with CF aged 6-12 years before and after starting ETI. Methods: We conducted a prospective observational single-centre study including children with CF commencing ETI who had no prior exposure to CFTR modulators, inhaled antibiotics, or prophylactic antibiotics. Lower airway microbiology was assessed longitudinally using sputum or induced sputum (IS). Pathogen prevalence, sweat chloride concentration, pulmonary function, nutritional status, and rate of exacerbations were evaluated before and up to 12 months after ETI initiation. Results: Sixteen pwCF were included (median age 8.4 years, 69 % boys, 75% were F508del homozygous). None of the children was expectorant at any point during the study. Following ETI initiation, we observed decreased growth of methicillin-sensitive Staphylococcus aureus and Aspergillus fumigatus, reduced variability in fungal populations, and an increase in negative bacterial and fungal culture results. Conclusions: In this exploratory study of young, modulator-naïve children with CF, ETI initiation was associated with changes in the lower airway microbiology composition assessed by IS. These findings highlight potential shifts in lower airway microbiology and the importance of age-appropriate lower airway sampling in future paediatric studies. Ključne besede: children, cystic fibrosis, elexacaftor/tezacafot/ivacaftor, respiratory pathogens Objavljeno v DiRROS: 24.04.2026; Ogledov: 258; Prenosov: 190
Celotno besedilo (1,50 MB) Gradivo ima več datotek! Več... |
8. The genetic blueprint of obesity : from pathogenesis to novel therapiesGašper Tonin, Stjepan Eržen, Zala Mlinarič, Dubravka Jurišić-Eržen, Simon Horvat, Tanja Kunej, Jasna Klen, 2025, pregledni znanstveni članek Ključne besede: CRISPR/Cas9, dual therapy, energy homeostasis, gene therapy, gut–brain axis, microbiota, personalized medicine Objavljeno v DiRROS: 22.04.2026; Ogledov: 165; Prenosov: 146
Celotno besedilo (6,03 MB) Gradivo ima več datotek! Več... |
9. Recent advances in experimental functional characterization of GWAS candidate genes in osteoporosisPetra Malavašič, Jasna Lojk, Nika Lovšin, Janja Marc, 2025, pregledni znanstveni članek Povzetek: Osteoporosis is a multifactorial, polygenic disease characterized by reduced bone mineral density (BMD) and increased fracture risk. Genome-wide association studies (GWASs) have identified numerous loci associated with BMD and/or bone fractures, but functional characterization of these target genes is essential to understand the biological mechanisms underlying osteoporosis. This review focuses on current methodologies and key examples of successful functional studies aimed at evaluating gene function in osteoporosis research. Functional evaluation typically follows a multi-step approach. In silico analyses using omics datasets expression quantitative trait loci (eQTLs), protein quantitative trait loci (pQTLs), and DNA methylation quantitative trait loci (mQTLs) help prioritize candidate genes and predict relevant biological pathways. In vitro models, including immortalized bone-derived cell lines and primary mesenchymal stem cells (MSCs), are used to explore gene function in osteogenesis. Advanced three-dimensional culture systems provide additional physiological relevance for studying bone-related cellular processes. In situ analyses of patient-derived bone and muscle tissues offer validation in a disease-relevant context, while in vivo studies using mouse and zebrafish models enable comprehensive assessment of gene function in skeletal development and maintenance. Integration of these complementary methodologies helps translate GWAS findings into biological insights and supports the identification of novel therapeutic targets for osteoporosis. Ključne besede: in silico analyses, omics, MSC, human bone tissue gene expression, gene knockdown Objavljeno v DiRROS: 22.04.2026; Ogledov: 186; Prenosov: 124
Celotno besedilo (2,05 MB) Gradivo ima več datotek! Več... |
10. Addressing viral hepatitis C reinfections in a low-threshold programme for people who inject drugs in SloveniaJasna Černoša, Jelka Meglič-Volkar, Mario Poljak, Maja Pohar Perme, Jeffrey Victor Lazarus, Mojca Matičič, 2025, izvirni znanstveni članek Povzetek: Background: Hepatitis C virus (HCV) infection remains a public health threat. Although therapy with direct-acting antivirals made its elimination possible, major challenges remain in treating vulnerable populations, such as people who inject drugs (PWID) enrolled in low-threshold programmes (LTPs). This study analysed the outcome of HCV management focused on HCV reinfection in a specifically designed model-of-care (MoC) for PWID in Slovenia, where treatment is prescribed without limitations, though only by specialist physicians. Methods: All HCV antibody (anti-HCV) positive users of a MoC, combining HCV management at Clinic for Infectious Diseases at the University Medical Centre in Ljubljana and LTP for PWID in 100 km distanced civil society organisation (CSO) Svit Koper, between January 2017 to December 2022, were included. The MoC enabled regular transportation of PWID between LTP and the Clinic, where specifically assigned services for individually tailored HCV management in cooperation with CSO were available. Data on participants´ demographic, epidemiological, and clinical characteristics were collected partly retrospectively and prospectively, with a particular focus on HCV treatment outcome and reinfection status, and analysed accordingly. Results: The study included 49 anti-HCV positive PWID with a mean age of 38.7 (standard deviation (SD) = 7.6) years at first visit. The majority was male (40/49, 81.6%); 16/49 (32.7%) experienced previous incarceration, 14/49 (28.6%) were experiencing homelessness, and 42/49 (85.7%) were receiving opioid agonist therapy. A total of 42/49 (83.7%) were HCV RNA-positive. Of them 36/42 (85.7%) started HCV treatment at a mean age of 42.7 (SD = 5.7) years and 33/36 (91.7%) completed treatment. Six (14.3%) HCV RNA-positive PWID died. Among 28/33 (84.9%) who achieved a sustained virological response 12 weeks post treatment, 6/28 (21.4%) presented with reinfection. The HCV reinfection rate was 13.3 per 100 - PY (95% confidence interval (CI) [6.0, 29.7]), the rate of positive HCV RNA re-test was 12.2 per 100 - PY (95%CI [7.7-16.7]), while hazard of reinfection in our cohort increased with time, with the estimated reinfection probability exceeding 0.5 at 4 years. Conclusions: In marginalised population of PWID attending LTP, a sustainable HCV RNA re-screening and follow-up after HCV cure are necessary, as the risk of reinfection remains high. Ključne besede: hepatitis C, micro-elimination, people who inject drugs, low-treshold settings, reinfection, Slovenia Objavljeno v DiRROS: 14.04.2026; Ogledov: 204; Prenosov: 165
Celotno besedilo (1,64 MB) Gradivo ima več datotek! Več... |